DRL logo

Biobank

Human Biospecimens, Primary Cells,
and 3D Cancer Models

Every model starts with a real patient tumor, procured fresh with clinical metadata intact. Browse our inventory, check availability, and request a quote.
Browse Available Models:
Ready to talk?
Not sure which model fits your study?
50K+
cases in biobank
33 hospitals - 18 clinics - 4 continents
30+
cancer types available
low passage - patient-derived - characterized
Days
not months, like PDX
organoids - spheroids - co-cultures

Why choose DRL

Now that FDA Modernization Act 2.0 lets non‑animal methods stand in for traditional animal tests, organoid platforms have become a strategic necessity, not a ‘nice‑to‑have.

  • Real Patient Tumors

    Not cell lines. Not mice. Our models originate directly from patient tumors — giving you the most predictive preclinical data available.
  • Global Biobank Diversity
    Samples from 33 hospitals and 18 clinics across North America, Europe, Asia, and Africa — the ethnic diversity global drug programs require.
  • Days, Not Months
    In-stock models ship within 2–3 weeks. No PDX delays. No building from scratch. Your timeline stays on track.
  • US-Based & Customizable
    Simpler compliance for US buyers. And if our catalog does not have exactly what you need, we can procure to spec.
  • Pharma-Grade QC
    Every model is biomarker-authenticated, mycoplasma-free, and genomically verified — the same quality standard used by top-tier pharma clients.

3D Organoid Models

Ideal for:
Drug Sensitivity Screening, Biomarker Validation, Co-culture Assays, and Personalized Oncology Research.
Sample Type
3D tumor organoid culture
Format
Cryovial with cell suspension preserved in CryoStor
Quality
50% post‑thaw viability; genomic match
biosafety level
BSL‑2
Storage & Shipping
≤ −150 °C; dry ice shipment
Cell type
Availability
Lead Time
Breast Invasive Carcinoma
In Stock
Ships in 2-3 weeks
Non-Small Cell Lung Cancer
Adenocarcinoma, Squamous
Cell Carcinoma
In Stock
Ships immediately
Prostate Adenocarcinoma
In Stock
Ships immediately
Colorectal Adenocarcinoma
In Stock
Ships in 2-3 weeks
Ovarian Carcinoma
Procurement
Lead time: 3 months
Pancreatic Ductal Adenocarcinoma
Procurement
Lead time: 3 months
Head and Neck Squamous Cell Carcinoma
Procurement
Lead time: 3 months
Our patient-derived tumor organoids are grown directly from fresh surgical specimens — not immortalized cell lines. Each model retains the genetic and structural features of the original tumor, giving you a predictive screening platform that animal models and standard cell lines simply cannot match.
With 50%+ post-thaw viability guaranteed and genomic match confirmed, you can run your assay with confidence from day one.

Primary cells

Biosamples

Questions & Answers

How quickly can I receive a model?
In-stock models typically ship within 2–3 weeks on dry ice. Custom procurement takes approximately 3 months.
What QC data is provided with each model?
All models include biomarker authentication, mycoplasma testing, viability data (50%+ post-thaw), and genomic match confirmation.
Can I request a specific cancer subtype or patient profile?
Yes. Contact us with your specifications and we will confirm availability or initiate a custom procurement from our global network of 33 hospitals across 4 continents.
How is pricing determined?
Pricing depends on disease type, quantity, and format (cryovial, pellet, or processed). Send us your requirements and we will provide a detailed quote within 24–48 hours.
DRL logo
Contract research organization, which provides solutions for pharma and diagnostics companies, including consulting, cancer models development, and various assays for drug development.
contact
28047 Dorothy Drive, #204,
Agoura Hills, CA 91301, USA
Call: +1 442-224-3375
E-mail: Info@drlus.com
©2026 DRL US. All Rights Reserved.

Biobank: Request Availability and Pricing

Ready to test on real patient tumors? Tell us the cancer type, format, and quantity you need. We’ll confirm availability and send a quote within 48 hours.